US20140052273A1 - Filler for removing wrinkles - Google Patents

Filler for removing wrinkles Download PDF

Info

Publication number
US20140052273A1
US20140052273A1 US14/114,184 US201214114184A US2014052273A1 US 20140052273 A1 US20140052273 A1 US 20140052273A1 US 201214114184 A US201214114184 A US 201214114184A US 2014052273 A1 US2014052273 A1 US 2014052273A1
Authority
US
United States
Prior art keywords
main body
filler
removing wrinkles
wrinkles according
hollow portion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/114,184
Other languages
English (en)
Inventor
Hoon-Bum Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HBMEDICALS CO Ltd
Original Assignee
HBMEDICALS CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HBMEDICALS CO Ltd filed Critical HBMEDICALS CO Ltd
Assigned to HBMEDICALS CO., LTD. reassignment HBMEDICALS CO., LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LEE, HOON-BUM
Publication of US20140052273A1 publication Critical patent/US20140052273A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0059—Cosmetic or alloplastic implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A61L27/165—Rubbers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743—Type of operation; Specification of treatment sites
    • A61B2017/00792—Plastic surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06166—Sutures
    • A61B2017/06176—Sutures with protrusions, e.g. barbs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06166—Sutures
    • A61B2017/06185—Sutures hollow or tubular
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors

Definitions

  • the present disclosure relates to a filler for removing wrinkles, more particularly to a filler which is inserted into the subcutaneous layer around wrinkles through cosmetic surgery and removes the wrinkles by inducing formation of new fibrous tissue.
  • wrinkles are formed on the skin surface of the face or body.
  • the wrinkles are formed because of muscular contraction.
  • the wrinkles are formed perpendicularly to the direction of muscle contraction and become deeper with aging.
  • Botox is frequently used to paralyze the muscles which cause wrinkles.
  • the effect lasts only 3-6 months.
  • a filler is used to correct wrinkles and other depressions in the skin.
  • a liquid filler is convenient to inject, it tends to move toward the direction of muscle contraction after being injected into the skin. As a result, the wrinkles may look deeper and, it is limited in that it is degraded and absorbed by the body after a predetermined time (up to about 1-2 years).
  • Another method is to insert a very thin gold thread into the subcutaneous layer.
  • the gold thread induces growth of new tissue around the thread through foreign body reactions.
  • this method is limited to be used for thick wrinkles and the inserted gold thread may be bent by external force or protrude out of the skin. Also, it may cause diagnostic problems during X-ray, CT or MRI imaging through interference.
  • the present disclosure is directed to providing a filler for removing wrinkles that is not moved after being inserted into the subcutaneous layer without resorting, for example, to surgical skin incision regardless of muscle contraction.
  • the present disclosure is also directed to providing a filler for removing wrinkles that provides (semi)permanently lasting wrinkle-removing effect after being inserted into the subcutaneous layer even when the filler itself is degraded and absorbed by the body with time since it induces formation of new fibrous tissue including collagen fiber.
  • the present disclosure is also directed to providing a filler for removing wrinkles that can be applied to various wrinkles including thick wrinkles and has recoiling force against external force.
  • a filler for removing wrinkles including: a thin and long tubular main body provided so as to penetrate the subcutaneous layer; and through-holes provided so as to guide tissue cells surrounding the main body into the main body to form fibrous tissue, wherein the through-holes are formed to communicate with a hollow portion formed in the main body in a lengthwise direction from the outer surface of the main body.
  • the main body of the filler for removing wrinkles has a circular transection.
  • the main body may have an outer diameter of 0.6-1.0 mm
  • the hollow portion may have a diameter (inner diameter of the main body) of 0.5-0.7 mm
  • the through-holes may have a diameter of 40-500 ⁇ m.
  • the main body of the filler for removing wrinkles is made of an elastic material.
  • the main body of the filler for removing wrinkles is made of a biodegradable polymer selected from a group consisting of hyaluronic acid (HA), polylactic acid (PLA), polyglyco-lactic acid (PGLA) and polydioxanone (PDS).
  • HA hyaluronic acid
  • PLA polylactic acid
  • PGLA polyglyco-lactic acid
  • PDS polydioxanone
  • the main body of the filler for removing wrinkles is made of a non-biodegradable polymer selected from a group consisting of nylon, silicone and Teflon.
  • the main body may have a double-layer structure including an inner sheath and an outer sheath made of different materials having different physical properties.
  • a plurality of partitions may be further formed in the hollow portion in the main body of the filler for removing wrinkles.
  • a spiral elastic support may be further formed in the hollow portion in the main body of the filler for removing wrinkles.
  • a spiral elastic support may be provided outside the main body of the filler for removing wrinkles so as to surround the outer surface of the main body.
  • a filler for removing wrinkles Since a filler for removing wrinkles according to the present disclosure has recoiling force, it is not deformed or moved by the pressure or external force applied on the skin after being inserted into the subcutaneous layer. Since a large quantity of new fibrous tissue including collagen fiber can be formed in a hollow portion of a main body of the filler through through-holes provided on the outer surface of the main body, the filler can be applied to various wrinkles including thick wrinkles by adjusting the diameter of the main body, the diameter of the hollow portion, the diameter of the through-holes, etc. depending on the size and kind of the wrinkles. Furthermore, the wrinkle-removing effect may last (semi)permanently since new fibrous tissue is formed.
  • FIG. 1 is a perspective view of a filler for removing wrinkles according to an exemplary embodiment of the present disclosure.
  • FIG. 2 is a perspective view of a filler for removing wrinkles according to another exemplary embodiment of the present disclosure.
  • FIG. 3 is a longitudinal sectional view of a filler for removing wrinkles according to another exemplary embodiment of the present disclosure wherein partitions are formed.
  • FIG. 4 is a longitudinal sectional view of a filler for removing wrinkles according to another exemplary embodiment of the present disclosure wherein a spiral elastic support is provided.
  • FIG. 5 shows fibrous tissue formed in a hollow portion of a filler for removing wrinkles according to the present disclosure inserted into the subcutaneous layer.
  • FIG. 6 shows a filler for removing wrinkles according to another exemplary embodiment of the present disclosure which is improved to allow easy insertion into a curved part.
  • FIG. 7 shows the filler for removing wrinkles according to the embodiment shown in FIG. 6 which is inserted into a curved part.
  • FIG. 8 shows a filler for removing wrinkles according another exemplary embodiment of the present disclosure wherein elastic cogs projecting in one direction are provided on the outer surface of a main body of the filler for removing wrinkles.
  • FIG. 9 shows the filler for removing wrinkles according to the embodiment shown in FIG. 8 being inserted into the subcutaneous layer.
  • FIG. 10 shows the filler for removing wrinkles according to the embodiment shown in FIG. 8 inserted into the subcutaneous layer.
  • FIG. 1 is a perspective view of a filler for removing wrinkles according to an exemplary embodiment (first embodiment) of the present disclosure.
  • a filler 10 for removing wrinkles according to the present disclosure includes: a thin and long, integral tubular main body 12 provided so as to penetrate the subcutaneous layer; and through-holes 14 provided so as to guide tissue cells surrounding the main body 12 into the main body 12 to form fibrous tissue, wherein the through-holes 14 are formed to communicate with a hollow portion 12 c formed in the main body 12 in a lengthwise direction from the outer surface of the main body 12 .
  • the filler 10 for removing wrinkles may have, for example, a circular transection (Also, it may have a hexagonal transection.).
  • the thin and long tubular main body 12 may be formed by spirally winding a plurality of strip-shaped parts 12 a, 12 b which is made of the material of the main body 12 of the filler 10 for removing wrinkles and which is having a predetermined width b along the surface of a long core material 20 having a diameter desired for the hollow portion 12 c so as to cross each other (in a manner similar to making a bamboo wife from bamboo cane).
  • the core material 20 may be removed, such that the hollow portion 12 c is formed in the parts 12 a, 12 b in a lengthwise direction, and the through-holes 14 may be formed by the gaps between the parts 12 a, 12 b (including the gaps formed at the crossing of the parts).
  • the thin and long tubular main body 12 may be formed by various methods which are spirally winding the plurality of parts 12 a, 12 b so as to cross each other, without using the core material.
  • FIG. 2 shows an example wherein two parts 12 a, 12 b, i.e.
  • a first part 12 a and a second part 12 b are used to form the filler 10 for removing wrinkles according to the present disclosure
  • the thin and long tubular main body 12 may be formed by spirally winding a plurality of strip-shaped parts as to cross each other, without being limited thereto.
  • the main body 12 may have a circular or polygonal (e.g., tetragonal, hexagonal, octagonal, etc.) transection. Specifically, it may have a circular transection, so that it can be easily inserted into the subcutaneous layer after being threaded on a needle (e.g., a needle for cosmetic surgery). Specifically, the main body 12 may have a diameter of 0.6-1.0 mm, so that it can be easily inserted into the subcutaneous layer and be located between the subcutaneous fat layer and the dermis or in the fat layer after being inserted. The length of the main body 12 is not particularly limited as long as it is enough for insertion.
  • the hollow portion 12 c formed in the main body 12 in the lengthwise direction provides a space, so that nearby tissue cells such as fibroblasts are guided through the through-holes 14 and then fibrous tissue such as elastic fibrous tissue and collagen tissue is newly formed. Accordingly, since the amount of newly formed fibrous tissue increases as the diameter of the hollow portion 12 c is larger and the amount of newly formed fibrous tissue decreases as the diameter of the hollow portion 12 c is smaller, the diameter of the hollow portion 12 c may be adequately adjusted depending on the depth, location, etc. of wrinkles. In general, the diameter of the hollow portion 12 c may be 0.5-0.7 mm.
  • the through-holes 14 provide a passage for fibroblasts, etc. to enter the hollow portion 12 c. They may have any shape, including circular, triangular, tetragonal, octagonal, trapezoidal and rhombic shapes.
  • the plurality of through-holes 14 may be arranged regularly or irregularly on the outer surface of the main body 12 . Specifically, the through-holes 14 may have a diameter, when they have a circular shape, or a circle-equivalent diameter, when they have other shapes, of 40-500 ⁇ m. If the diameter is too large, the filler 10 may not be able to support the surrounding tissues.
  • the main body 12 may be made of an elastic material. It may be made of a biodegradable polymer such as hyaluronic acid (HA), polylactic acid (PLA), polyglyco-lactic acid (PGLA) and polydioxanone (PDS) or a non-biodegradable polymer such as nylon, silicone and Teflon. If a biodegradable polymer is used, the filler for removing wrinkles is slowly degraded and absorbed after the fibrous tissue is formed. If a non-biodegradable polymer is used, the filler for removing wrinkles remains permanently in the subcutaneous layer.
  • HA hyaluronic acid
  • PLA polylactic acid
  • PGLA polyglyco-lactic acid
  • PDS polydioxanone
  • the main body 12 may have a double-layer structure including an inner sheath and an outer sheath made of different materials having different physical properties.
  • the inner sheath may be formed of a hard material and the outer sheath may be formed of a soft material.
  • the inner sheath may be formed of an absorbent material and the outer sheath may be formed of a non-absorbent material, or the inner sheath and the outer sheath may be formed of absorbent materials having different rate of absorption.
  • the filler for removing wrinkles according to the present disclosure has recoiling force so as to endure the pressure or external force applied on the skin without collapsing after being inserted into the subcutaneous layer.
  • a plurality of partitions 16 may be formed in the hollow portion 12 c to reinforce the recoiling force, as shown in FIG. 3 .
  • the partitions 16 may be formed to completely or incompletely divide the hollow portion 12 c of the main body 12 .
  • the partitions 16 may be made of the same material as the main body 12 .
  • a spiral elastic support 17 may be formed in the hollow portion 12 c to reinforce the recoiling force, as shown in FIG. 4 .
  • the spiral elastic support 17 may be formed outside the main body 12 so as to surround the outer surface of the main body 12 .
  • the spiral elastic support 17 may be made of the same material as the main body 12 .
  • the spiral elastic support 17 may allow easier insertion into a curved part since, when the filler for removing wrinkles according to the present disclosure is inserted into the subcutaneous layer with a curved shape, the spiral structure can become narrower or wider depending on the curvature.
  • a filler 10 for removing wrinkles as shown in FIG. 6 may be provided.
  • a plurality of main bodies 12 are disposed in a row such that individual hollow portions 12 c are adjacent to each other, and a connector 12 d penetrating the hollow portions 12 c formed in the main bodies 12 in a lengthwise direction is further provided so that the plurality of main bodies 12 are used as a series of fillers for removing wrinkles.
  • the filler 10 for removing wrinkles can be more easily inserted into the subcutaneous layer with a curved shape, as shown in FIG. 7 .
  • a filler 10 for removing wrinkles wherein elastic cogs 12 e are formed on the outer surface of a main body 12 by partially cutting the surface may be provided, as shown in FIG. 8 .
  • the plurality of elastic cogs 12 e projecting in one direction are further formed on the outer surface of the main body 12 along the lengthwise direction of the main body 12 .
  • the elastic cogs 12 e remain folded (the elastic cogs are accommodated in grooves partially cut on the outer surface) in the subcutaneous layer while the filler 10 for removing wrinkles is being inserted into the subcutaneous layer, as shown in FIG. 9 .
  • the elastic cogs 12 e restore to the original state of projecting in one direction from the main body 12 (see FIG. 8 ) owing to elasticity, as shown in FIG. 10 .
  • the restored elastic cogs 12 e are caught by tissues and prevent the filler 10 for removing wrinkles from retreating in the subcutaneous layer, thereby ensuring fixation to the subcutaneous layer.
  • growth factors for facilitating the formation of fibrous tissue may be coated on the outer surface or inner surface of the main body 12 or included in the main body 12 .
  • the growth factor may be angiogenesis factor, platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), transforming growth factor-a (TGF- ⁇ ), transforming growth factor- ⁇ (TGF- ⁇ ), epidermal growth factor (EGF), connective tissue growth factor (CTGF), vascular endothelial growth factor (VEGF), etc., but is not limited thereto.
  • the filler for removing wrinkles according to the present disclosure may be easily inserted by threading one end thereof on a needle for cosmetic surgery or by connecting to the tip of the needle according to a commonly employed method.
  • a method for removing wrinkles using the filler for removing wrinkles according to the present disclosure will be described in detail referring to FIG. 5 .
  • a wrinkled area to which the filler is to be inserted is marked and an anesthetic ointment is applied thereon. Then, a needle is inserted from one end of the marked area into the subcutaneous layer, particularly between the subcutaneous fat layer and the dermis or into the fat layer, and pulled at the other end, such that the filler for removing wrinkles spans over the marked area. Then, the portion coming out of the skin S is removed by cutting. Subsequently, blood, red blood cells, white blood cells, platelets, fibroblasts, myofibroblasts, etc. are filled in a hollow portion 12 c of the filler 10 for removing wrinkles inserted into the subcutaneous layer.
  • the amount of the fibroblasts reaches maximum 3-5 days after the insertion, and that of the myofibroblasts reaches maximum at 5-15 days. Thereafter, collagen is synthesized by the fibroblasts, resulting in fibrous tissue T.
  • the fibrous tissue T provides a wrinkle-correcting effect.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Prostheses (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
US14/114,184 2011-04-28 2012-04-27 Filler for removing wrinkles Abandoned US20140052273A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020110040057A KR101256908B1 (ko) 2011-04-28 2011-04-28 주름제거용 충전체
KR10-2011-0040057 2011-04-28
PCT/KR2012/003291 WO2012148216A2 (ko) 2011-04-28 2012-04-27 주름제거용 충전체

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/003291 A-371-Of-International WO2012148216A2 (ko) 2011-04-28 2012-04-27 주름제거용 충전체

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/335,757 Continuation US10357349B2 (en) 2011-04-28 2016-10-27 Filler for removing wrinkles

Publications (1)

Publication Number Publication Date
US20140052273A1 true US20140052273A1 (en) 2014-02-20

Family

ID=47072939

Family Applications (2)

Application Number Title Priority Date Filing Date
US14/114,184 Abandoned US20140052273A1 (en) 2011-04-28 2012-04-27 Filler for removing wrinkles
US15/335,757 Active 2033-03-16 US10357349B2 (en) 2011-04-28 2016-10-27 Filler for removing wrinkles

Family Applications After (1)

Application Number Title Priority Date Filing Date
US15/335,757 Active 2033-03-16 US10357349B2 (en) 2011-04-28 2016-10-27 Filler for removing wrinkles

Country Status (11)

Country Link
US (2) US20140052273A1 (ko)
EP (1) EP2702959B1 (ko)
JP (1) JP2014512913A (ko)
KR (1) KR101256908B1 (ko)
CN (1) CN103648436B (ko)
BR (1) BR112013027629A2 (ko)
CA (1) CA2834177A1 (ko)
ES (1) ES2693131T3 (ko)
RU (1) RU2013151654A (ko)
SG (1) SG194644A1 (ko)
WO (1) WO2012148216A2 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101362446B1 (ko) * 2012-05-10 2014-02-11 이훈범 주름제거용 충전체
KR101696253B1 (ko) 2013-05-10 2017-01-13 주식회사 에스트라 주름제거용 충전제
KR101682534B1 (ko) 2013-06-20 2016-12-06 주식회사 에스트라 피부 리프팅 또는 조직의 볼륨 팽창용 봉합사
WO2015083864A1 (ko) * 2013-12-06 2015-06-11 주식회사 와이제이콥스메디칼 의료용 관 삽입 장치 및 이를 구비한 의료용 관 삽입 시술 키트

Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262418A (en) * 1990-03-06 1993-11-16 Tanssen Pharmaceutica N.V. N-(4-piperidinyl) (dihydroxybenzofuran or dihydro-2H-benzopyran)carboxamide derivatives
US5556426A (en) * 1994-08-02 1996-09-17 Meadox Medicals, Inc. PTFE implantable tubular prostheses with external coil support
US5769884A (en) * 1996-06-27 1998-06-23 Cordis Corporation Controlled porosity endovascular implant
US6245040B1 (en) * 1994-01-14 2001-06-12 Cordis Corporation Perfusion balloon brace and method of use
US20020015957A1 (en) * 2000-04-29 2002-02-07 Hageman Gregory S. Diagnostics and therapeutics for macular degeneration-related disorders
US20020090725A1 (en) * 2000-11-17 2002-07-11 Simpson David G. Electroprocessed collagen
US20020123790A1 (en) * 1999-09-28 2002-09-05 White Geoffrey Hamilton Enhanced engagement member for anchoring prosthetic devices in body lumen
US20020151957A1 (en) * 2001-04-11 2002-10-17 Andrew Kerr Axially-connected stent/graft assembly
US6517571B1 (en) * 1999-01-22 2003-02-11 Gore Enterprise Holdings, Inc. Vascular graft with improved flow surfaces
US20040034407A1 (en) * 2002-08-16 2004-02-19 John Sherry Covered stents with degradable barbs
US20040098095A1 (en) * 1997-12-18 2004-05-20 Burnside Diane K. Stent-graft with bioabsorbable structural support
US20050283256A1 (en) * 2004-02-09 2005-12-22 Codman & Shurtleff, Inc. Collagen device and method of preparing the same
US20080275569A1 (en) * 2004-09-16 2008-11-06 Evera Medical, Inc Tissue Augmentation Device
US20090024226A1 (en) * 2004-09-16 2009-01-22 Evera Medical, Inc. Methods of forming a tissue implant having a tissue contacting layer held under compression
US20100057196A1 (en) * 2006-10-12 2010-03-04 C.R. Bard, Inc. Vascular grafts with multiple channels and methods for making
US20110137331A1 (en) * 2009-12-07 2011-06-09 Michael Walsh Perfusion device
US20120310367A1 (en) * 2011-05-31 2012-12-06 Lifecell Corporation Adipose tissue matrices

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4034763A (en) * 1976-06-10 1977-07-12 Frazier Calvin H Ligament forming suture
US5395331A (en) * 1992-04-27 1995-03-07 Minnesota Mining And Manufacturing Company Retrograde coronary sinus catheter having a ribbed balloon
US5522881A (en) * 1994-06-28 1996-06-04 Meadox Medicals, Inc. Implantable tubular prosthesis having integral cuffs
US6245103B1 (en) * 1997-08-01 2001-06-12 Schneider (Usa) Inc Bioabsorbable self-expanding stent
US8458879B2 (en) * 2001-07-03 2013-06-11 Advanced Bio Prosthetic Surfaces, Ltd., A Wholly Owned Subsidiary Of Palmaz Scientific, Inc. Method of fabricating an implantable medical device
US20020198544A1 (en) * 2001-06-22 2002-12-26 Renan Uflacker Percutaneous facelift device
US20050152943A1 (en) * 2003-12-23 2005-07-14 Medtronic Vascular, Inc. Medical devices to treat or inhibit restenosis
WO2005096955A1 (en) * 2004-04-07 2005-10-20 Tze Liang Woffles Wu Surgical thread
KR20050108494A (ko) * 2004-05-12 2005-11-17 김영복 돌기를 가지는 성형외과용 수술실
US7244270B2 (en) * 2004-09-16 2007-07-17 Evera Medical Systems and devices for soft tissue augmentation
KR100679160B1 (ko) * 2004-09-20 2007-02-05 마렌 안드레비치 술라마니즈 성형수술용 수술실
CN2776300Y (zh) * 2004-12-31 2006-05-03 王恩铎 乳突样阻力管皮肤除皱线
CN1977779A (zh) * 2005-12-08 2007-06-13 上海康德莱企业发展集团有限公司 带药物涂层的血管支架
KR100745571B1 (ko) * 2006-06-15 2007-08-03 이정일 성형수술용 선형인장재
JP4255960B2 (ja) * 2006-06-16 2009-04-22 克弥 高須 形成外科用手術糸
CA2658548A1 (en) * 2006-07-25 2008-01-31 Jeffrey E. Yeung Spooled filament to repair tissue
WO2008070425A2 (en) * 2006-11-16 2008-06-12 Microaire Surgical Instruments, Inc. Packaged wrinkle-filling grafts and method for cosmetically reducing the appearance of wrinkles
CN101385669B (zh) * 2007-09-12 2010-12-08 中国科学院金属研究所 一种抗凝血不锈钢冠动脉支架及其应用
US8721666B2 (en) * 2007-09-26 2014-05-13 Ethicon, Inc. Method of facial reconstructive surgery using a self-anchoring tissue lifting device
US20090099597A1 (en) * 2007-10-12 2009-04-16 Isse Nicanor G Suture assembly with tissue engaging elements
KR100888082B1 (ko) * 2007-11-15 2009-03-11 황귀환 성형용 보형물
US8226684B2 (en) * 2008-12-22 2012-07-24 Ethicon, Inc. Surgical sutures having collapsible tissue anchoring protrusions and methods therefor
KR101062318B1 (ko) * 2009-05-19 2011-09-05 김형수 의료시술용 보형물
PL2448498T3 (pl) * 2009-06-29 2017-08-31 Aesculap Ag Nić chirurgiczna zawierająca komórki i sposób jej wytwarzania

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262418A (en) * 1990-03-06 1993-11-16 Tanssen Pharmaceutica N.V. N-(4-piperidinyl) (dihydroxybenzofuran or dihydro-2H-benzopyran)carboxamide derivatives
US6245040B1 (en) * 1994-01-14 2001-06-12 Cordis Corporation Perfusion balloon brace and method of use
US5556426A (en) * 1994-08-02 1996-09-17 Meadox Medicals, Inc. PTFE implantable tubular prostheses with external coil support
US5769884A (en) * 1996-06-27 1998-06-23 Cordis Corporation Controlled porosity endovascular implant
US20040098095A1 (en) * 1997-12-18 2004-05-20 Burnside Diane K. Stent-graft with bioabsorbable structural support
US6517571B1 (en) * 1999-01-22 2003-02-11 Gore Enterprise Holdings, Inc. Vascular graft with improved flow surfaces
US20020123790A1 (en) * 1999-09-28 2002-09-05 White Geoffrey Hamilton Enhanced engagement member for anchoring prosthetic devices in body lumen
US20020015957A1 (en) * 2000-04-29 2002-02-07 Hageman Gregory S. Diagnostics and therapeutics for macular degeneration-related disorders
US20020090725A1 (en) * 2000-11-17 2002-07-11 Simpson David G. Electroprocessed collagen
US20020151957A1 (en) * 2001-04-11 2002-10-17 Andrew Kerr Axially-connected stent/graft assembly
US20040034407A1 (en) * 2002-08-16 2004-02-19 John Sherry Covered stents with degradable barbs
US20050283256A1 (en) * 2004-02-09 2005-12-22 Codman & Shurtleff, Inc. Collagen device and method of preparing the same
US20080275569A1 (en) * 2004-09-16 2008-11-06 Evera Medical, Inc Tissue Augmentation Device
US20090024226A1 (en) * 2004-09-16 2009-01-22 Evera Medical, Inc. Methods of forming a tissue implant having a tissue contacting layer held under compression
US20100057196A1 (en) * 2006-10-12 2010-03-04 C.R. Bard, Inc. Vascular grafts with multiple channels and methods for making
US20110137331A1 (en) * 2009-12-07 2011-06-09 Michael Walsh Perfusion device
US20120310367A1 (en) * 2011-05-31 2012-12-06 Lifecell Corporation Adipose tissue matrices

Also Published As

Publication number Publication date
EP2702959A2 (en) 2014-03-05
SG194644A1 (en) 2013-12-30
BR112013027629A2 (pt) 2017-02-14
CA2834177A1 (en) 2012-11-01
EP2702959A4 (en) 2015-01-28
KR101256908B1 (ko) 2013-04-23
KR20120122083A (ko) 2012-11-07
CN103648436B (zh) 2017-02-08
EP2702959B1 (en) 2018-08-01
JP2014512913A (ja) 2014-05-29
US20170042653A1 (en) 2017-02-16
US10357349B2 (en) 2019-07-23
ES2693131T3 (es) 2018-12-07
RU2013151654A (ru) 2015-06-10
CN103648436A (zh) 2014-03-19
WO2012148216A3 (ko) 2013-03-07
WO2012148216A2 (ko) 2012-11-01

Similar Documents

Publication Publication Date Title
US10357349B2 (en) Filler for removing wrinkles
RU2573804C2 (ru) Имплантат для подтяжки ткани
US20170079764A1 (en) Filler for removing wrinkles
RU2528077C2 (ru) Нить, имеющая закрепляющие элементы с покрытием для закрепления в биологических тканях, и способ ее получения
US20080046094A1 (en) Linear tension material for plastic surgery
KR102114925B1 (ko) 성형 시술용 실 및 이를 이용한 시술도구
BR112013024303B1 (pt) Sistema de sutura de autorretenção e método para fabricar um sistema de sutura de autorretenção
DE102009020901A1 (de) Beschichteter Faden mit Verankerungsstrukturen zur Verankerung in biologischen Geweben
KR101532704B1 (ko) 봉합사 리프팅용 캐뉼라
DE102009020894A1 (de) Elastomerer Faden mit Verankerungsstrukturen zur Verankerung in biologischen Geweben
US20060058890A1 (en) Methods for soft tissue augmentation
KR102270487B1 (ko) 신체 부분을 거상 또는 구속하는 장치 및 방법
RU2465844C2 (ru) Устройство для подтяжки лица и шеи
JP6654312B2 (ja) 分岐点が設けられたリフティング用手術器具
KR101534061B1 (ko) 폭경비가 다른 개구를 구비한 봉합사 리프팅용 캐뉼라
KR101548372B1 (ko) 돌출둔단봉합사를 구비하는 블런트엔드니들
KR20160137102A (ko) 리프팅용 생체 삽입용 실
KR20210092015A (ko) 생분해성 봉합사 및 이를 포함하는 수술용 봉합사
RU2611910C1 (ru) Шовный материал для косметических операций
RU2584079C1 (ru) Хирургическая нить (варианты)
RU2609057C1 (ru) Шовный материал для косметических операций
KR102610210B1 (ko) 탄성으로 유발되는 통증을 완화하는 의료용 실 삽입 장치
KR20220040316A (ko) 탄성력이 우수한 성형수술용 탄력실
KR20230004011A (ko) 메쉬를 이용한 코 성형용 리프팅 사
JP2023086124A (ja) 改良型リフト糸およびその製造方法

Legal Events

Date Code Title Description
AS Assignment

Owner name: HBMEDICALS CO., LTD., KOREA, REPUBLIC OF

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:LEE, HOON-BUM;REEL/FRAME:031483/0305

Effective date: 20131021

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION